Advertisement

Topics

Gilead Sciences Establishes CAR-T Manufacturing Toehold in Europe Ahead of EMA Decision

20:00 EDT 14 May 2018 | BioSpace

In anticipation of marketing approval in Europe, Gilead Sciences has leased a 117,000 square-foot facility in The Netherlands to manufacture and deliver Yescarta, its CAR-T product, to patients across Europe.

Original Article: Gilead Sciences Establishes CAR-T Manufacturing Toehold in Europe Ahead of EMA Decision

NEXT ARTICLE

More From BioPortfolio on "Gilead Sciences Establishes CAR-T Manufacturing Toehold in Europe Ahead of EMA Decision"

Advertisement
Quick Search
Advertisement
Advertisement